Saturday, 31 October 2026European Markets

POSTNL, CTT CORREIOS PORT, Another 1 Companies Have A High Dividend Yield And Return On Equity In The Integrated Freight & Logistics Industry.

Loading stream...

(vianews) - postnl (pnl.as) is among this list of stock assets with the highest dividend rate and return on equity on the integrated freight & logistics industry.

financial asset price forward dividend yield return on equity
postnl (pnl.as) €1.27 4.7% 28.5%
ctt correios port (ctt.ls) €3.55 3.46% 19.89%
stef (stf.pa) €123.20 3.4% 14.17%

several euronext companies pay out dividends to its shareholders. the dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.

1. postnl (pnl.as)

4.7% forward dividend yield and 28.5% return on equity

postnl n.v. provides postal and logistics services to businesses and consumers in the netherlands, rest of europe, and internationally. the company operates in two segments, parcels and mail in the netherlands; and postnl other. it collects, sorts, transports, and delivers letters and parcels; and offers data management, direct marketing, and fulfillment services, as well as cross-border mail and parcels solutions. the company was formerly known as tnt n.v. and changed its name to postnl n.v. in may 2011. postnl n.v. is headquartered in the hague, the netherlands.

earnings per share

as for profitability, postnl has a trailing twelve months eps of €0.11.

pe ratio

postnl has a trailing twelve months price to earnings ratio of 11.57. meaning, the purchaser of the share is investing €11.57 for every euro of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 28.5%.

revenue growth

year-on-year quarterly revenue growth grew by 0.7%, now sitting on 3.16b for the twelve trailing months.

moving average

postnl's worth is under its 50-day moving average of €1.35 and way below its 200-day moving average of €1.65.

dividend yield

as claimed by morningstar, inc., the next dividend payment is on apr 18, 2024, the estimated forward annual dividend rate is 0.06 and the estimated forward annual dividend yield is 4.7%.

volume

today's last reported volume for postnl is 624296 which is 76.01% below its average volume of 2602700.

more news about postnl.

2. ctt correios port (ctt.ls)

3.46% forward dividend yield and 19.89% return on equity

ctt - correios de portugal, s.a., together with its subsidiaries, provides postal and financial services worldwide. it operates through mail, express & parcels, financial services & retail, and bank segments. the company offers courier and urgent mail transport services; postal financial services; and banking services. it also engages in the business of payments related to collection of invoices and fines. in addition, the company enables the payment of various services and utilities through a network of approximately 5,000 agents covering business outlets as stationery stores, tobacco shops, kiosks, and supermarkets. it operates a retail network of 566 post offices; 1,808 postal agencies; 223 postal delivery offices; 4,576 postal delivery routes; and a fleet of 3,925 vehicles. the company was formerly known as correio publico. ctt - correios de portugal, s.a. was founded in 1520 and is headquartered in lisbon, portugal.

earnings per share

as for profitability, ctt correios port has a trailing twelve months eps of €0.31.

pe ratio

ctt correios port has a trailing twelve months price to earnings ratio of 11.44. meaning, the purchaser of the share is investing €11.44 for every euro of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 19.89%.

yearly top and bottom value

ctt correios port's stock is valued at €3.55 at 21:40 est, under its 52-week high of €3.81 and higher than its 52-week low of €3.23.

revenue growth

year-on-year quarterly revenue growth grew by 8.6%, now sitting on 970.94m for the twelve trailing months.

more news about ctt correios port.

3. stef (stf.pa)

3.4% forward dividend yield and 14.17% return on equity

stef sa provides temperature-controlled road transport and logistics services for agri-food industry, and out-of-home foodservices. it transports fresh, frozen, and thermosensitive products; and seafood products. the company also provides maritime passenger and freight transport services between marseille and corsica; and co-packing services. it operates in france, italy, spain, portugal, belgium, the netherlands, switzerland, and the united kingdom. the company was founded in 1920 and is headquartered in paris, france.

earnings per share

as for profitability, stef has a trailing twelve months eps of €11.48.

pe ratio

stef has a trailing twelve months price to earnings ratio of 10.73. meaning, the purchaser of the share is investing €10.73 for every euro of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 14.17%.

more news about stef.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
ESMO 2026 Oncology Data Wave Builds Toward Ivonescimab PDUFA, While Micro-Cap Biotech Exits the Market
Late October 2026 is a dense catalyst window led by ESMO 2026. Daiichi Sankyo's DXd antibody-drug conjugate (ADC) programs (DESTINY-Lung04, DESTINY-Breast11, REJOICE-Ovarian01/02, TUXEDO-3), Guardant's 25 abstracts and the PACE-LUNG ctDNA trial all report there. These feed into the FDA's 14 November 2026 PDUFA date for ivonescimab. Large and mid-cap developers with late-stage data and commercial launches (ZEGFROVY, ANKTIVA, MIUDELLA, lorundrostat, duvakitug) are drawing capital and attention. Spago Nanomedical's board decision to seek a Nasdaq First North delisting (EGM 19 November, application 25 January 2027) shows the capital squeeze on early-stage, single-asset names (Tumorad is Phase I).
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,994
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,994 facts checked against source5,514 source documents archived
Query this data → isubstrate.com